Tandem Diabetes Care
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $290,383 | $249,253 | $240,678 | $234,422 |
Gross Profit | 167,460 | 134,292 | 125,855 | 118,407 |
EBITDA | 11,252 | -18,585 | -50,818 | -116,421 |
EBIT | 6,757 | -23,078 | -55,185 | -120,732 |
Net Income | -589 | -21,165 | -52,400 | -130,556 |
Net Change In Cash | 290,383 | 249,253 | 240,678 | 234,422 |
Free Cash Flow | 3,104 | 4,171 | -15,702 | -21,243 |
Cash | 90,634 | 91,947 | 64,112 | 53,574 |
Basic Shares | 68,014 | 67,652 | 67,050 | 66,404 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,014,736 | $940,203 | $747,718 | $801,217 |
Gross Profit | 530,847 | 489,574 | 367,690 | 412,986 |
EBITDA | -174,699 | -99,127 | -196,460 | -74,209 |
EBIT | -192,365 | -99,285 | -212,175 | -88,539 |
Net Income | -204,710 | -96,025 | -222,611 | -94,594 |
Net Change In Cash | 1,014,736 | 940,203 | 747,718 | 801,217 |
Cost of Revenue | 100,509 | |||
Free Cash Flow | -29,669 | 4,994 | -58,614 | 16,367 |
Cash | 90,634 | 69,234 | 58,868 | 172,517 |
Basic Shares | 67,285 | 65,451 | 64,968 | 64,146 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.01 |
2025-09-30 | -$0.31 |
2025-06-30 | -$0.78 |
